Back to Search Start Over

Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression.

Authors :
Sharon, Yael
Friling, Ronit
Luski, Moshe
Campoverde, Belén Quizhpe
Amer, Radgonde
Kramer, Michal
Source :
Ocular Immunology & Inflammation. Dec2017, Vol. 25 Issue 6, p740-747. 8p.
Publication Year :
2017

Abstract

<bold>Purpose: </bold>To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression.<bold>Methods: </bold>Retrospective study of uveitic glaucoma patients in two tertiary medical centers in 2003-2015. Patient- and disease-related data was retrieved. Clinical parameters and visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure ≤21 mmHg and preserving visual fields.<bold>Results: </bold>Included were 34 patients (53 eyes), with a mean follow-up of 7 years. Idiopathic anterior uveitis and open-angle glaucoma were most common. In total, 62% of eyes were steroid responders. Higher IOP was associated with posterior synechiae, peripheral-anterior synechiae, steroidal, and immunomodulatory therapy (p<0.05). Glaucomatous field defects developed in 49%, with most showing no progression, despite elevation of cup-to-disc ratio (p<0.05).<bold>Conclusions: </bold>Chronic severe uveitis, expressed by structural complications and immunomodulatory therapy, was associated with high IOP and the need for more IOP lowering medications, but was unrelated to glaucomatous damage. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09273948
Volume :
25
Issue :
6
Database :
Academic Search Index
Journal :
Ocular Immunology & Inflammation
Publication Type :
Academic Journal
Accession number :
126917805
Full Text :
https://doi.org/10.1080/09273948.2016.1255341